A carregar...
Microvascular Outcomes in Patients with Type 2 Diabetes Treated with Vildagliptin vs. Sulfonylurea: A Retrospective Study Using German Electronic Medical Records
INTRODUCTION: Preliminary data suggest that dipeptidyl peptidase-4 (DPP-4) inhibitors may reduce microvascular events, but there is a little evidence to support this from adequate real-world studies. This study aimed to compare microvascular outcomes between patients-prescribed vildagliptin and thos...
Na minha lista:
Publicado no: | Diabetes Ther |
---|---|
Main Authors: | , , , , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
Springer Healthcare
2016
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5014784/ https://ncbi.nlm.nih.gov/pubmed/27262995 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13300-016-0177-8 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|